• Home
  • About Us
    • Who We Are
    • In What We Believe
    • Team
  • Services
    • Services
    • Quality Assurance
    • Why You Should Choose Us
  • Blog
  • Careers
  • SAS Trainings
    • Upcoming Trainings
    • History of SAS Base Trainings
      • Training in cooperation with Ministry of HTI of RA
      • Cooperation with ASUE
      • The Biggest SAS Base Training in the Region
  • Ecosystem
  • Contacts
  • Home
  • About Us
    • Who We Are
    • In What We Believe
    • Team
  • Services
    • Services
    • Quality Assurance
    • Why You Should Choose Us
  • Blog
  • Careers
  • SAS Trainings
    • Upcoming Trainings
    • History of SAS Base Trainings
      • Training in cooperation with Ministry of HTI of RA
      • Cooperation with ASUE
      • The Biggest SAS Base Training in the Region
  • Ecosystem
  • Contacts
  • Home
  • About Us
    • Who We Are
    • In What We Believe
    • Team
  • Services
    • Services
    • Quality Assurance
    • Why You Should Choose Us
  • Blog
  • Careers
  • SAS Trainings
    • Upcoming Trainings
    • History of SAS Base Trainings
      • Training in cooperation with Ministry of HTI of RA
      • Cooperation with ASUE
      • The Biggest SAS Base Training in the Region
  • Ecosystem
  • Contacts
  • Home
  • About Us
    • Who We Are
    • In What We Believe
    • Team
  • Services
    • Services
    • Quality Assurance
    • Why You Should Choose Us
  • Blog
  • Careers
  • SAS Trainings
    • Upcoming Trainings
    • History of SAS Base Trainings
      • Training in cooperation with Ministry of HTI of RA
      • Cooperation with ASUE
      • The Biggest SAS Base Training in the Region
  • Ecosystem
  • Contacts
A New “Miracle Cure” for Asthma.
Home Blog A New “Miracle Cure” for Asthma.
Blog

A New “Miracle Cure” for Asthma.

Asthma is a disease that affects more than 5 million people in the UK. The sad fact is that four out of five people with suspected severe asthma are not referred to specialists for treatment that could change and even save their lives.

NICE has published a Final Evaluation Report (FAD) recommending dupilumab as an additional supportive treatment for severe asthma.

Dupilumab (also called Dupixent) will be available to patients by injection. These injections are given every few weeks, and in clinical trials they have been shown to reduce the frequency of asthma attacks in combination with standard inhalers.

Asthma UK and the British Lung Foundation are calling on NICE to develop clear new guidelines so that healthcare professionals are confident about when to refer patients with possible severe asthma for the specialized care they so desperately need.

21
Shreya Siddanagouder's New HandsShreya Siddanagouder's New HandsOctober 21, 2021
International Stuttering Awareness DayOctober 22, 2021International Stuttering Awareness Day

Related Posts

Blog
International Day of Women and Girls in Science
February 11, 2022 by admin
Blog
World Cancer Day
February 4, 2022 by admin

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Categories
  • Blog (30)
  • Careers (2)
  • COVID-19 (9)
  • Ecosystem (1)
  • Innovation (2)
  • Technology (3)
  • Uncategorized (1)
Archives
  • May 2022 (1)
  • March 2022 (2)
  • February 2022 (3)
  • December 2021 (1)
  • November 2021 (1)
  • October 2021 (5)
  • September 2021 (1)
  • August 2021 (1)
  • July 2021 (7)
  • June 2021 (4)
  • May 2021 (1)
  • April 2021 (1)
  • March 2021 (1)
  • July 2020 (3)
  • April 2020 (1)
  • March 2020 (4)
  • November 2019 (2)
  • May 2019 (2)
  • February 2019 (1)

Copyright © 2021 The Gurus. All rights reserved

#blog_module_641efe89e74b5.blog-posts .blog-post_title, #blog_module_641efe89e74b5.blog-posts .blog-post_title a { font-size:24px; line-height:36px; font-weight:700; }#blog_module_641efe89e74b5.blog-posts .blog-post_text { font-size:14px; line-height:24px; }#integrio_soc_icon_wrap_641efe89ea632 a{ background: #ffffff; border-color: #ffffff; }#integrio_soc_icon_wrap_641efe89ea632 a:hover{ background: #664bc4; border-color: #0f5f9e; }.integrio_module_social #soc_icon_641efe89ea6721{ color: #ffffff; }.integrio_module_social #soc_icon_641efe89ea6721:hover{ color: #4661c5; }.integrio_module_social #soc_icon_641efe89ea6721{ background: #4661c5; }.integrio_module_social #soc_icon_641efe89ea6721:hover{ background: #ffffff; }.integrio_module_social #soc_icon_641efe89ea6952{ color: #ffffff; }.integrio_module_social #soc_icon_641efe89ea6952:hover{ color: #0f5f9e; }.integrio_module_social #soc_icon_641efe89ea6952{ background: #0f5f9e; }.integrio_module_social #soc_icon_641efe89ea6952:hover{ background: #ffffff; }